CIK: 0001744967 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 16, 2020
Total Value ($000): $358,514 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Forma Therapeutics Holdings, Inc. | 1,492,163 | $74,369 | 20.7% | $46.49 | — | COM | 34633R104 |
| NKTX | Nkarta, Inc. | 2,034,703 | $61,163 | 17.1% | $29.47 | 0.0% | COM | 65487U108 |
| — | Iveric Bio, Inc. | 3,370,478 | $19,009 | 5.3% | $5.74 | — | COM | 46583P102 |
| — | Springworks Therapeutics Inc | 398,017 | $18,973 | 5.3% | $21.68 | — | COM | 85205L107 |
| — | CureVac N.V. | 370,385 | $17,241 | 4.8% | $46.55 | — | COM | N2451R105 |
| — | Sutro BioPharma Inc | 1,675,579 | $16,840 | 4.7% | $8.61 | — | COM | 869367102 |
| — | Intercept Pharmaceuticals Inc | 403,688 | $16,737 | 4.7% | $88.27 | — | COM | 45845P108 |
| — | Allakos Inc | 192,334 | $15,666 | 4.4% | $51.45 | — | COM | 01671P100 |
| — | Unum Therapeutics, Inc. | 5,681,818 | $13,295 | 3.7% | $2.34 | — | COM | 903214104 |
| — | Syros Pharmaceuticals Inc | 1,407,949 | $11,608 | 3.2% | $6.82 | — | COM | 87184Q107 |
| — | Odonate Therapeutics Inc | 815,421 | $10,951 | 3.1% | $14.27 | — | COM | 676079106 |
| — | Atreca Inc | 617,560 | $8,627 | 2.4% | $17.99 | — | COM | 04965G109 |
| — | Verona Pharma PLC. | 1,111,112 | $6,933 | 1.9% | $6.18 | — | SPONS ADS | 925050106 |
| — | Aeglea BioTherapeutics, Inc. | 883,720 | $6,266 | 1.7% | $9.25 | — | COM | 00773J103 |
| EQ | Equillium, Inc. | 1,074,285 | $6,199 | 1.7% | $8.10 | 0.0% | COM | 29446K106 |
| ACRS | Aclaris Therapeutics, Inc. | 2,153,265 | $5,534 | 1.5% | $1.36 | +64.4% | COM | 00461U105 |
| — | BCTG Acquisition Corp | 500,000 | $5,180 | 1.4% | $10.36 | — | COM | 05492W103 |
| RYTM | Rhythm Pharmaceuticals Inc | 234,846 | $5,089 | 1.4% | $17.90 | +28.0% | COM | 76243J105 |
| — | Panacea Acquisition Corp. | 400,000 | $4,800 | 1.3% | $12.00 | — | UNIT | 698102209 |
| — | Alpine Immune Sciences Inc | 494,190 | $4,344 | 1.2% | $8.79 | — | COM | 02083G100 |
| — | Kala Pharmaceuticals Inc | 451,162 | $3,384 | 0.9% | $9.52 | — | COM | 483119103 |
| — | Albireo Pharma, Inc. | 100,000 | $3,337 | 0.9% | $33.37 | — | COM | 01345P106 |
| GERN | Genron Corporation | 1,531,088 | $2,664 | 0.7% | $1.49 | +23.7% | COM | 374163103 |
| — | Allovir, Inc | 91,057 | $2,504 | 0.7% | $27.50 | — | COM | 019818103 |
| NVAX | Novavax, Inc. | 21,660 | $2,347 | 0.7% | $121.82 | 0.0% | COM | 670002401 |
| FULC | Fulcrum Therapeutics, Inc. | 294,118 | $2,332 | 0.7% | $15.75 | -23.5% | COM | 359616109 |
| RCKT | Rocket Pharmaceuticals Inc | 99,643 | $2,278 | 0.6% | $19.67 | +25.2% | COM | 77313F106 |
| — | Aimmune Therapeutics, Inc. | 58,142 | $2,003 | 0.6% | $14.42 | — | COM | 00900T107 |
| — | Catabasis Pharmaceuticals Inc | 300,000 | $1,857 | 0.5% | $4.37 | — | COM | 14875P206 |
| SPRO | Spero Therapeutics, Inc. | 160,000 | $1,786 | 0.5% | $11.83 | 0.0% | COM | 84833T103 |
| UROV | Urovant Sciences Ltd | 157,480 | $1,471 | 0.4% | $6.59 | — | COM | G9381B108 |
| — | Hookipa Pharma Inc | 116,602 | $1,104 | 0.3% | $6.73 | — | COM | 43906K100 |
| KALV | KalVista Pharmaceuticals Inc | 84,087 | $1,059 | 0.3% | $18.15 | -31.1% | COM | 483497103 |
| BNTX | BioNTech SE | 12,700 | $879 | 0.2% | $69.21 | — | SPONS ADS | 09075V102 |
| — | NGM Biopharmaceuticals, Inc. | 36,451 | $580 | 0.2% | $19.73 | — | COM | 62921N105 |
| — | Amarin Corp PLC | 25,000 | $105 | 0.0% | $4.00 | — | SPONS ADR NEW | 023111206 |